A New Challenge for the Neuroradiologist: MR Recognition of Mitochondrial Dysfunction in Children Born of HIV-Seropositive Mothers on Antiretroviral Therapy

References

1. ↵
   Blanche 00, et al. Cerebral magnetic resonance imaging in children born to HIV seropositive mothers and perinatally exposed to zidovudine. AJNR Am J Neuroradiol 2004; this issue
2. ↵
   Connor EM, Sperling RS, Gelber R, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type I with zidovudine treatment. N Engl J Med 1994;331:1173–1118

   CrossRefPubMedWeb of Science
3. ↵
   Taylor GP, Low-Beer N. Antiretroviral therapy in pregnancy: a focus on safety. Drug Safe 2001;24:683–702
4. ↵
   Blanche S, Rouzioux C, Moscato ML, et al. A prospective study of infants born to women seropositive for human immunodeficiency virus type I: HIV infection in newborns French collaborative study group. N Engl J Med 1989;320:1643–1648

   CrossRefPubMedWeb of Science
5. ↵
   Barret B, Tardieu M, Rustin P, et al. Mitochondrial dysfunction in HIV uninfected children. AIDS 2003;17:1769–1785

   CrossRefPubMedWeb of Science
6. ↵
   Gerschenson M, Erhart SW, Paik CY, et al. Fetal mitochondrial heart and skeletal muscle damage in erythrocebus patas monkeys exposed to in utero to 3′-azido-3′-deoxythymidine. AIDS Res Hum Retrivuruses 2000;16:635–644
7. ↵
   Munoz A, Mateos F, Simon R, et al. Mitochondrial diseases in children: neuroradiological and clinical features in 17 patients. Neuroradiology 1999;41:920–928

   CrossRefPubMedWeb of Science
8. ↵
   Blanche S, Tardieu M, Rustin P, et al. Persistent mitochondrial dysfunction and perinatal exposure to antiretroviral nucleoside analogues. Lancet 1999;354:1084–1089

   CrossRefPubMedWeb of Science
9. ↵
   Culnane M, Fowler M, Lee SS, et al. Lack of long-term effects of in utero exposure to zidovudine among uninfected children born to HIV-infected women: Pediatric AIDS Clinical Trials Group Protocol 219/076 Teams. JAMA 1999;281:151–157

   CrossRefPubMedWeb of Science
10. ↵
    Perinatal Safety Review Working Group. Nucleoside exposure in the children of HIV-infected women receiving antiretroviral drugs: absence of clear evidence for mitochondrial disease in children who died before 5 years of age in five United States cohorts. J Acquir Immune Defic Syndr 2000;25:261–268
11. ↵
    Shiramizu B, Shikuma KM, Kanemoto L, et al. Placenta and cord blood mitochondrial DNA toxicity in HIV-infected women receiving nucleoside reverse transcriptase inhibitors during pregnancy. J Acquir Immune Defic Syndr 2003;32:370–374
12. ↵
    Mantovani A, Calamandrei G. Delayed developmental effects following prenatal exposure to drugs. Curr Pharm Des 2001;7:859–880

    CrossRefPubMed
13. ↵
    Poirier MC, Divi RL, Al-Harthi L, et al. Long-term mitochondrial toxicity in HIV- uninfected infants born to HIV-infected mothers. J Acquir Immune Defic Syndr 2003;33:175–183